Julieta Saba

Julieta Saba

Auto-generated profile, based on publicly available information

Julieta Saba

Instituto de Investigaciones Biomédicas (INBIOMED) UBA-CONICET, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2017 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
LCLila Carniglia
Lila Carniglia
DRDelia Ramírez
Delia Ramírez
DDDaniela Durand
Daniela Durand
JSJulieta Saba
Julieta Saba
JTJuan Turati
Juan Turati
MLMercedes Lasaga
Mercedes Lasaga
Microglial cells are responsible for immune surveillance within the CNS. They respond to noxious stimuli by releasing inflammatory mediators and mounting an effective inflammatory response. This is followed by release of anti-inflammatory mediators and resolution of the inflammatory response. Alterations to this delicate process may lead to tissue damage, neuroinflammation, and neurodegeneration. Chronic pain, such as inflammatory or neuropathic pain, is accompanied by neuroimmune activation, and the role of glial cells in the initiation and maintenance of chronic pain has been the subject of increasing research over the last two decades. Neuropeptides are small amino acidic molecules with the ability to regulate neuronal activity and thereby affect various functions such as thermoregulation, reproductive behavior, food and water intake, and circadian rhythms. Neuropeptides can also affect inflammatory responses and pain sensitivity by modulating the activity of glial cells. The last decade has witnessed growing interest in the study of microglial activation and its modulation by neuropeptides in the hope of developing new therapeutics for treating neurodegenerative diseases and chronic pain. This review summarizes the current literature on the way in which several neuropeptides modulate microglial activity and response to tissue damage and how this modulation may affect pain sensitivity.

1 November 2020 in Neurochemistry International
Verified
Journal Article
Closed access
JTJuan Turati
Juan Turati
DRDelia Ramírez
Delia Ramírez
LCLila Carniglia
Lila Carniglia
JSJulieta Saba
Julieta Saba
CCCarla Caruso
Carla Caruso
MLMercedes Lasaga
Mercedes Lasaga

11 April 2022 in Journal of Neurochemistry
Verified
Journal Article
Closed access
JTJuan Turati
Juan Turati
JRJulieta Rudi
Julieta Rudi
JBJuan Beauquis
Juan Beauquis
LCLila Carniglia
Lila Carniglia
FCFederico López Couselo
Federico López Couselo
DDDaniela Durand
Daniela Durand

1 September 2024 in CNS & Neurological Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
FCFederico López Couselo
Federico López Couselo
JSJulieta Saba
Julieta Saba
LCLila Carniglia
Lila Carniglia
DDDaniela Durand
Daniela Durand
MLMercedes Lasaga
Mercedes Lasaga
CCCarla M Caruso
Carla M Caruso
Astrocytes are glial cells that perform several fundamental physiological functions within the brain. They can control neuronal activity and levels of ions and neurotransmitters, and release several factors that modulate the brain environment. Over the past few decades, our knowledge of astrocytes and their functions has rapidly evolved. Neurodegenerative diseases are characterized by selective degeneration of neurons, increased glial activation, and glial dysfunction. Given the significant role played by astrocytes, there is growing interest in their potential therapeutic role. However, defining their contribution to neurodegeneration is more complex than was previously thought. This review summarizes the main functions of astrocytes and their involvement in neurodegenerative diseases, highlighting their neurotoxic and neuroprotective ability.